Quantcast

Latest David Samadi Stories

2011-03-08 14:54:00

NEW YORK, March 8, 2011 /PRNewswire/ -- In a study conducted by the National Institutes of Health in Bethesda, Maryland and published in Cancer Epidemiology and Biomarkers, statistics suggest a strong link between a male individual's Body Mass Index (BMI) and the likelihood that they will develop aggressive, high-grade prostate cancer. Dr. David Samadi, Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York...

2010-12-29 10:44:00

NEW YORK, Dec. 29, 2010 /PRNewswire/ -- Dr. David Samadi, the Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, wrapped up his groundbreaking trip to Israel with the completion of six successful robotic prostate cancer treatment surgeries. Via these prostate cancer surgeries, three of which were televised live, Samadi demonstrated his SMART technique (Samadi Modified Advanced Robotic Technique) to...

2010-12-23 14:50:00

NEW YORK, Dec. 23, 2010 /PRNewswire/ -- Dr. David Samadi, robotic prostatectomy expert, as well as the Vice Chairman, Department of Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, continues to break barriers by sharing his robotic surgery and prostate cancer treatment skills with doctors worldwide. Today, Samadi, a pioneer surgeon in the field of robotics, performed his signature SMART Surgery Technique at Rambam Medical...

2010-12-14 11:54:00

NEW YORK, Dec. 14, 2010 /PRNewswire/ -- A new study in the journal Cancer shows that staging prostate cancer that has not metastasized beyond the prostate gland does predict the outcome, prognosis or risk of cancer recurrence after a radical prostatectomy. "This study confirms what many prostate cancer treatment surgeons have thought about staging - it's irrelevant after prostate cancer surgery - something I strongly disagree with," said Dr. David Samadi, a robotic surgery expert, as well...

2010-12-08 15:15:00

NEW YORK, Dec. 8, 2010 /PRNewswire/ -- Androgen deprivation therapy has often been prescribed as a prostate cancer treatment for low-risk prostate cancer patients. This therapy for treating prostate cancer had previously been blamed for increased risk of cardiovascular disease and heart conditions. However, this hormone treatment for prostate cancer has now become more controversial due to its two potential side effects, diabetes and obesity, which are risk factors for colorectal cancer....

2010-11-17 14:30:00

NEW YORK, Nov. 17, 2010 /PRNewswire/ -- A new technique has been discovered that could potentially impact research of prostate cancer and how the tumor functions. The technique surgically removes a normal and cancerous prostate gland and keeps it alive and functioning in a lab for up to a week. "This discovery is significant because it could eventually result in individualized medications and prostate cancer treatments for patients," said Dr. David Samadi, a robotic prostatectomy expert,...

2010-11-10 17:40:00

NEW YORK, Nov. 10, 2010 /PRNewswire/ -- Aspirin comes to the rescue again, as a potential prostate cancer treatment option. A new study presented at the American Society for Radiation Oncology (ASTRO) in San Diego, shows that it may cut the risk of dying for men with prostate cancer that has not spread beyond the prostate gland. "The study showed that prostate cancer patients taking blood thinning, or anticoagulant medication, specifically aspirin, had a lower risk of mortality, more so in...

2010-11-02 16:57:00

NEW YORK, Nov. 2, 2010 /PRNewswire/ -- According to the U.S. Agency for Healthcare Research and Quality (AHRQ), compared to men in 1999, American men in 2006 that were fighting prostate cancer were 45% less likely to die from the disease. "There is no specific reason for this decline, but I believe early detection and prostate cancer treatment education and awareness are probably major factors," said Dr. David Samadi, a robotic surgery expert, as well as the new Vice Chairman, Department of...

2010-10-27 17:27:00

NEW YORK, Oct. 27 /PRNewswire/ -- Drugs, known as gonadotropin-releasing hormone (GnRH) agonists, may raise diabetes and heart risk and, as a result, now need new warnings. U.S. health officials said the drug used to stem the production of testosterone, the hormone that contributes to prostate cancer growth, could also lead to sudden death. "The risk of diabetes, heart disease and sudden death in men undergoing prostate cancer treatment with these drugs does not appear to be elevated,...

2010-10-26 14:37:00

NEW YORK, Oct. 26 /PRNewswire/ -- British scientists have identified a protein in urine that can help indicate which patients are at an increased risk of developing prostate cancer. The Cancer Research UK Cambridge Research Institute and The Institute of Cancer Research found that the level of MSMB protein in urine could provide a fast and accurate prostate cancer diagnosis for doctors and patients, potentially replacing the currently painful and more costly approach - a blood sample. Dr....


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related